Q2 2023 13F Holders as of 6/30/2023
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
6.99M
-
Number of holders
-
18
-
Total 13F shares, excl. options
-
2.35M
-
Shares change
-
+671K
-
Total reported value, excl. options
-
$19M
-
Value change
-
+$5.87M
-
Number of buys
-
11
-
Number of sells
-
-3
-
Price
-
$9.14
Significant Holders of Minerva Neurosciences, Inc. - Common Stock (NERV) as of Q2 2023
19 filings reported holding NERV - Minerva Neurosciences, Inc. - Common Stock as of Q2 2023.
Minerva Neurosciences, Inc. - Common Stock (NERV) has 18 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 2.35M shares
of 6.99M outstanding shares and own 33.63% of the company stock.
Largest 10 shareholders include FEDERATED HERMES, INC. (1.35M shares), FMR LLC (492K shares), VANGUARD GROUP INC (205K shares), RENAISSANCE TECHNOLOGIES LLC (98.3K shares), BlackRock Inc. (78.8K shares), GEODE CAPITAL MANAGEMENT, LLC (52K shares), ACADIAN ASSET MANAGEMENT LLC (21.5K shares), Virtu Financial LLC (21K shares), STATE STREET CORP (13.7K shares), and MORGAN STANLEY (9K shares).
This table shows the top 18 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.